Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2020/09/028150
CTRI/2020/09/028150
Recruiting
Phase 3

A comparative clinical study of plantar iontophoresis with aqueous solution of Nirgundi and 0.4% dexamethasone in the management of pada kanataka with special reference to Plantar fasciitis

Dr D Y Patil College of Ayurveda and research centre Pimpri Pune0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr D Y Patil College of Ayurveda and research centre Pimpri Pune
Status
Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr D Y Patil College of Ayurveda and research centre Pimpri Pune

Eligibility Criteria

Inclusion Criteria

  • •Patients presenting with clinical features of Pada\-kantaka (Plantar fasciitis)
  • •Age group between 20 yrs and 60 yrs
  • •Patients irrespective of gender, religion and economic status
  • •Patients with chronicity of 2\-3 months

Exclusion Criteria

  • •Patients not consenting to the trial
  • •Age group below 20 yrs and above 60 yrs
  • •Fracture of Calcaneus
  • •Calcaneal Spur
  • •Local infection of plantar surface of foot
  • •Patients with pacemaker, stents, metallic implants

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 2
Role of plantar iontophoresis in the management of padakantaka w.s.r. to plantar fasciitis.Health Condition 1: - Health Condition 2: M775- Other enthesopathy of foot
CTRI/2020/09/027936national institute of ayurveda
Not yet recruiting
Phase 2
Comparison of efficacy of iontophoresis with glycopyrrolate solution and tap water for palmar/plantar hyperhidrosis
CTRI/2022/10/046893MAHARISHI MARKANDESHWAR MEDICAL COLLEGE AND HOSPITA
Completed
Not Applicable
Study of the Safety and Efficacy of an Iontophoretic Device to Treat Recurrent Herpes Labialis
ISRCTN83097613Klearsen Corporation (USA)13
Completed
Not Applicable
Validation of developed iontophoretic device with disposable patches for pain management in clinical settings.Health Condition 1: D499- Neoplasm of unspecified behavior of unspecified site
CTRI/2019/09/021446Research Institute and hospital100
Active, not recruiting
Phase 2
Treatment for pain reduction and the size of heel spurPLANTAR FASCIITIS CALCIFYINGC04.588.894.797.520
RBR-6864tjPUC Minas